Effect of breast density on mammography radiation dose.
Breast density has only a minor impact on radiation dose during mammography examinations, according to a study published in The Breast Journal.
Researchers from the University of Virginia Health System in Charlottesville, performed a retrospective study to evaluate the relative contribution of breast density to the radiation dose from screening mammography.
The researchers collected patient age, weight, height, compressed breast thickness, and average glandular dose for each exposure for 434 sequential patients undergoing screening mammography. The median age of the patients was 58 and they had a median body mass index of 26.8. Median volumetric breast density was 5.8%, ranging from 1.7% to 30.5%.
The results showed that the median compressed breast thickness was 63.4 mm, ranging from 24.5 mm to 111.5 mm. Univariate analysis showed positive associations between radiation dose and both breast thickness and BMI, an inverse association with age, and no association with density. Multivariate regression analysis demonstrated a significant association between dose and age, laterality, BMI, density, and breast thickness.
There was larger overall attenuation with larger breast thickness, but the system automatic exposure control balanced this out by selecting a higher tube voltage (kVp) and/or current-time product settings.
The researchers determined that it was breast thickness that was the primary determinant of dose, accounting for 76% of the 58% of the dose variability, followed by density (8%), laterality (4%), age (less than 1%), and BMI (less than 1%). Compressed breast thickness had the greatest effect on average glandular dose. Breast density has a minor impact, while BMI and age have minimal impact on dose.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.